FEROX STRATEGIES

Lobbying for AVIDITY BIOSCIENCES, INC. · Biotechnology company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $80,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Issues related to rare disease pharmaceuticals, and general FDA reforms related to rare disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.